Stock GXGX GX ACQUISITION CORP.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

GX Acquisition Corp. Stock

Equities

GXGX

US36251A1079

Investment Holding Companies

Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site

Chart GX Acquisition Corp.

Dynamic Chart

Latest news about GX Acquisition Corp.

Celularity Closes Merger With GX Acquisition Corp MT
Celularity Inc. completed the acquisition of GX Acquisition Corp. in a reverse merger transaction. CI
GX Acquisition Corp. Approves Elections of Nine Directors CI
GX Acquisition Corp.(NasdaqCM:GXGX) dropped from NASDAQ Composite Index CI
Gx Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Palantir Technologies : Working With Celularity to Advance Cellular Therapies MT
GX ACQUISITION : BTIG Research Starts GX Acquisition at Buy With $16 Price Target MT
Gx Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Transcript : Celularity Inc., GX Acquisition Corp. - M&A Call
GX Acquisition : Celularity, GX Acquisition Corp. to Merge, Create a Publicly Listed Allogeneic Cellular Therapy Company MT
Celularity Inc. entered into non-binding letter of intent to acquire GX Acquisition Corp. for $1.7 billion in a reverse merger transaction. CI
Gx Acquisition Corp. Reports Earnings Results for the Third Quarter Ended September 30, 2020 CI
Gx Acquisition Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2020 CI
Gx Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2020 CI
Gx Acquisition Corp. Reports Earnings Results for the Third Quarter Ended September 30, 2019 CI
More news

Analyst Recommendations on GX Acquisition Corp.

GX ACQUISITION : BTIG Research Starts GX Acquisition at Buy With $16 Price Target MT
More recommendations

Press releases GX Acquisition Corp.

GX Acquisition : Clinical pipeline includes multiple clinical stage programs including acute myeloid leukemia (AML) and glioblastoma multiforme (GBM), with a total of five clinical programs expected by 1H 2022 (Form 8-K) PU
GX Acquisition : Submission of Matters to a Vote of Security Holders (Form 8-K) PU
GX ACQUISITION CORP. : Submission of Matters to a Vote of Security Holders (form 8-K) AQ
GX Acquisition : Arthrex to receive exclusive rights to distribute and commercialize Celularity’s placental-derived biomaterial products for orthopedics and sport medicine in the United States (Form 8-K) PU
GX ACQUISITION CORP. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) AQ
More press releases

Company Profile

GX Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company is not engaged in any business operations and it has not generated any revenue.
Sector
Investment Holding Companies
More about the company

Sector Shell Companies

1st Jan change Capi.
TRUMP MEDIA & TECHNOLOGY GROUP CORP. Stock Trump Media & Technology Group Corp.
+181.03% 6.72B
SCREAMING EAGLE ACQUISITION CORP. Stock Screaming Eagle Acquisition Corp.
+1.13% 1B
CHURCHILL CAPITAL CORP VII Stock Churchill Capital Corp VII
+2.10% 982M
APPLE ISPORTS GROUP, INC. Stock Apple iSports Group, Inc.
+41.91% 872M
PERELLA WEINBERG PARTNERS Stock Perella Weinberg Partners
+19.71% 783M
ARES ACQUISITION CORPORATION II Stock Ares Acquisition Corporation II
+1.72% 664M
ALTC ACQUISITION CORP. Stock AltC Acquisition Corp.
+41.57% 644M
DA ZHONG TRADING GROUP HOLDING COMPANY Stock Da Zhong Trading Group Holding Company
-.--% 600M
E7 GROUP Stock E7 Group
+10.41% 59.33M
Shell Companies
  1. Stock Market
  2. Equities
  3. GXGX Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW